ANTIBIOTIC PREPARED FROM LYSOBACTER SP. SC 14,067

Abstract: A novel antibiotic substance EM5587 is prepared by cul­ tivation of a strain of the microorganism Lysobacter sp. SC 14,067, A.T.C.C. No. 53042.

Description: Cultivation of a strain of the microorganism Lysobacter sp. SC 14,067, which has been deposited in the American Type Culture Collection as A.T.C.C. No. 53042 yields a novel antibiotic substance EM5587. The antibiotic has activity against a range of Gram-positive and Gram-negative bacteria, and has particularly good activity against Gram-positive bacteria. Figure 1 shows the ultraviolet spectrum of the trifluoroacetate salt of EM5587 in methanol. Figure 2 shows the infrared spectrum of the trifluoroacetate salt of EM5587 in potassium bromide. Figure 3 shows the fast atom bombardment mass spectrum of the trifluoroacetate salt of EM5587 in the positive mode. Figure 4 shows the 67.5 MHz ¹³C NMR spectrum of the trifluoroacetate salt of EM5587 in deuterated acetonitrile-deuterated water-trifluoroacetic acid (50:50:0.1). Figure 5 shows the 400 MHz ¹H NMR spectrum of the trifluoroacetate salt of EM5587 in deuterated acetonitrile-deuterated water-trifluoroacetic acid (50:50:0.1). The microorganism used for the production of EM5587 is a strain of Lysobacter sp. SC 14,067. A subculture of the microorganism can be obtained from the permanent collection of the American Type Culture Collection, Rockville, Maryland. Its accession number in this repository is A.T.C.C. No. 53042. In addition to the specific micoorganism described and characterized herein, it should be understood that mutants of the microorganism ( e.g. , mutants produced through the use of x-rays, ultraviolet radiation, or nitrogen mustards) can also be cultivated to produce EM5587. Isolation of Lysobacter sp. SC 14,067 from a sample of wet leaf litter (in this instance obtained from a stream in Washington's Crossing State Park, New Jersey) in which it is present can be accomplished by plating the soil onto Littman's agar (BBL Microbiology Systems, P.O. Box 243, Cockeysville, Maryland 21030) supplemented with a sterile streptomycin solution so the final concentration is 30µg/ml of medium. After 6 days incubation at about 25°C, the colonies of Lysobacter sp. SC 14,067 are isolated from the plated sample. The isolated colonies are picked off onto an agar medium composed of: Yeast extract 5.0 g Glucose 5.0 g MgSO₄.7H₂O 0.1 g FeSO₄.7H₂O 0.1 g Agar 17.5 g Tap water 800 ml Soil extract filtrate 200 ml The medium is sterilized in an autoclave at 121°C for 30 minutes. Lysobacter sp. SC 14,067 is a Gram-negative rod that exhibits varying morphology depending on the medium. In trypticase-soy agar, the cells are short rods with rounded ends and are fairly uniform in length. On 0.2% tryptone agar, the rods are thin, slightly flexuous and range in length from about 0.4 - 40 µm. On this medium, they exhibit characteristic gliding motility. No fruiting bodies are formed. Colonies are slimy or mucoid and a dirty yellow in color. On Hugh-Leifson's O/F glucose test, (J. Bacteriol., 66:24 (1953)), Lysobacter sp. SC 14,067 grows oxidatively, but no acid production is evident. The weak acid production is masked by ammonia from the peptone in the medium. On Board and Holding's peptone-free medium (Manual of Methods for General Bacteriology, eds. Gerhardt et al., A.S.M., Washington, D.C., 1981, p. 433) with monobasic ammonium phosphate at 0.05% as nitrogen source and 0.5% glucose as the sole carbon source, detectable acid is produced. The organism is cytochrome oxidase, catalase and phosphatase positive. Lysobacter sp. SC 14,067 is chitinolytic and lyses cells of yeasts, e.g. , Saccharomyces . It is strongly proteolytic on gelatin and casein. No cellulolytic or agarolytic activity is evident. Tests for indole, methyl red and the Voges-Proskauer reaction are all negative. The mole % G + C of Lysobacter sp. SC 14,067 DNA is 64.9. The above characteristics are all consistent with those of members of the genus Lysobacter as described by Christiansen and Cook (1978) Int. J. Bacteriol. 28 (3):367-393. The antibiotic EM5587 can be produced by cultivating Lysobacter sp. SC 14,067, A.T.C.C. No. 53042, at, or near, 25°C under submerged aerobic conditions in an aqueous nutrient medium containing assimilable carbohydrate and nitrogen sources. The fermentation is carried out until substantial activity is imparted to the medium, usually about 24-28 hours. After the fermentation is completed, the broth is centrifuged to separate the cells of the producing microorganism from the fermentation supernate. EM5587 is present in both the solid and liquid portions. The solids are extracted with acetone-water (4:1) and the extract is concentrated in vacuo to an oily residue. The residue is triturated with a minimal amount of methanol and the methanol soluble material is chromatographed on a column of MCI gel CHP2OP , eluting with water-acetonitrile-trifluoroacetic acid mixtures. Fractions active against Staphylococcus aureus that are homogeneous by TLC are combined. Crystallization can be achieved by evaporation of acetonitrile-water-trifluoroacetic acid solutions of EM5587 under a stream of nitrogen. The crystalline EM5587 trifluoroacetate salt is collected by vacuum filtration. The broth supernate is adjusted to pH 7.0, and is extracted with n -butanol. The butanol extract is concentrated in vacuo and then triturated and chromatographed in the same manner as described for the cell extract to provide EM5587 as its trifluoroacetate salt. Other salts can be prepared by passage of a water-acetonitrile (1:1, v/v) solution of EM5587 trifluoroacetate salt through a basic ion exchange resin, e.g. , AG MP-1 (Bio-Rad, Richmond, Calif.), in the appropriate anionic form. Exemplary inorganic salts are the hydrohalides (e.g. , the hydrochloride and hydrobromide), sulfate, nitrate, phosphate, and borate. Exemplary organic salts are the acetate, tartrate, maleate, citrate, succinate, benzoate, pamoate, ascorbate, salicylate, alkanesulfonates (e.g. , methanesulfonate) and arylsulfonates (e.g. , benzenesulfonate). Pharmaceutically acceptable salts of EM5587 can be used as agents to combat bacterial infections (particularly Gram-positive infections) in mammalian species, such as domesticated animals (e.g. , dogs, cats, cows, horses and the like) and humans. It can be administered using modes of administration which have been used in the past to deliver penicillins and ceplalosporins to the site of the infection. Such methods of administration include intravenous, intramuscular and as a suppository. The dosage of EM5587 used will, of course, vary with the size of the host and the severity of the infection. For a human adult, daily doses of about 250 milligrams to about 2 grams are exemplary. Further information about the potency of the compounds of this invention is set forth below under the heading "Biological Activity". The following example further describes the preparation and utility of the salts of EM5587. Example Lysobacter sp. SC 14,067, A.T.C.C. No.53042, was maintained on the following sterilized agar medium (A): Medium A Yeast extract 5.0 g Glucose 5.0 g MgSO₄.7H₂0 0.1 g FeSO₄.7H₂0 0.1 g Soil extract filtrate 200 ml Agar 17.5 g Tap water 800 ml A loopful of surface growth from an agar slant (Medium A) of Lysobacter sp. SC 14,067, A.T.C.C. No. 53042, was used to inoculate each of two 500 ml Erlenmeyer flasks each containing 100 ml of the following sterilized medium B: Medium B Yeast extract 5.0 g Peptone 3.0 g Mannitol 5.0 g Distilled water to 1.0 liter The medium was sterilized at 121°C for 15 minutes prior to use. After inoculation, the flasks were incubated at 25°C on a rotary shaker (300 rpm; 2 inch stroke) for approximately 24 hours. Transfers of 1% (vol./vol.) were made from the grown culture flasks to fifty 500 ml Erlenneyer flasks each containing 100 ml of sterilized medium B as described above. After inoculation, the flasks were once again incubated at 25°C on a rotary shaker (as previously described) for approximately 24-28 hours. At this time the contents of the flasks were combined and the broth was centrifuged yielding approximately 4.8 liters of supernatant broth and 33 g of cells (wet weight). The cell mass (33g) was extracted with three 200 ml portions of acetone water (4:1). The filtered extracts were combined and concentrated to dryness. The residue was triturated with methanol and the soluble portion was concentrated to a yellow glass (705 mg). Chromatography of the methanol soluble material was accomplished on a 2.5 x 43 cm column of MCI gel CHP20P, with a linear gradient prepared from 1 liter of 0.1% trifluoroacetic acid in water and 1 liter of 0.1% trifluoroacetic acid in acetonitrile. Fractions giving a single Rydon-positive component by TLC (Merck silica gel-60; n-butanol-acetic acid-water 4:1:1; Rf=0.42) were combined and dried to yield an off-white solid (173 mg). The solid was dissolved in acetonitrile-water-trifluoroacetic acid (50:50:0.1) and left to evaporate under a stream of nitrogen to afford 73 mg of crystalline EM5587 as its trifluoroacetate salt. Elemental analysis was performed on a sample after drying in vacuo at 70°C for 3 hours. Found: C, 50.01; H,6.92; N, 13.98; F, 7.4. The ultraviolet spectrum of the trifluoroacetate salt of EM5587 is presented in Figure 1 and shows: λmax 250 (sh, 1.4), 257 (1.5), 262 (1.4) and 268 nm (0.9) in addition to end absorption. The infrared spectrum of the trifluoroacetate salt of EM5587 in potassium bromide is shown in Figure 2. The following peaks are evident: 3345 (br), 2965, 2937, 2878, 1745 (w), 1666 (s), 1530 (s), 1203, 1138, 838, 800, 722, and 702 cm⁻¹. The FAB mass spectrum of the trifluoroacetate salt of EM5587 in dithiothreitol-dithioerythritol is shown in Figure 3. The 67.5 MHz ¹³C NMR spectrum of the trifluoroacetate salt of EM5587 in deuterated acetonitrile-deuterated water-trifluoroacetic acid (50:50:0.1) is shown in Figure 4. The 400 MHz ¹H NMR spectrum of the trifluoroacetate salt of EM5587 in deuterated acetonitrile-deuterated water-trifluoroacetic acid (50:50:0.1) is shown in Figure 5. Thin layer partition chromatography of the trifluoroacetate salt of EM5587 on Merck silica gel-60, using n-butanol-acetic acid-water (4:1:1) gives an Rf value of 0.42. The trifluoroacetate salt of EM5587 is soluble in methanol, acetonitrile-water (1:1) and dimethylsulfoxide, but is not substantially soluble in acetonitrile, chloroform, benzene, ethyl acetate or water. Biological Activity For aerobic bacteria, the minimum inhibitory concentration (MIC) of the trifluoroacetate salt of EM5587 was determined by an agar dilution technique. The test organisms were prepared from frozen stocks and diluted to give a final level of 10⁷ CFU/ml. The trifluoroacetate salt of EM5587 was dissolved in the appropriate diluent at a concentration of 1,000 µg/ml. Two fold dilutions were made in Yeast Beef Broth (Difco), resulting in a range from 1,000 µg/ml to 0.5 µg/ml. A 1.5 ml sample of each dilution was placed into individual petri dishes to which 13.5 ml of K-10 agar* was added. The final drug concentration in the agar ranged from 100 µg/ml to 0.05 µg/ml. Organism growth control plates containing agar only were prepared and inoculated before and after the test plates. The organisms were applied to the surface of each plate with the Denley Multipoint Inoculator (which delivers approximately 0.001 ml of each organism) resulting in a final inoculum level of 10⁴ CFU on the agar surface. The plates were incubated at 37°C for 18 hours and the MIC's then determined. The MIC is the lowest concentration of compound inhibiting growth of the organism. The results of the agar dilution assays are as follows. *K-10 agar is Beef extract 1.5 g Yeast extract 3.0 g Peptone 6.0 g Dextrose 1.0 g Agar 15.0 g Distilled water to 1000 ml The susceptibility of a number of anaerobic bacteria was also determined by an agar dilution technique. Test organisms were prepared from 24-48 hour cultures grown in Chopped Meat Broth (Scott Laboratories, Fiskeville, Rhode Island), or from washings from chocolate agar slants. These slants were prepared by adding hemoglobin to Protease #3 agar (Difco) to a concentration of 1 per cent. The growth was washed off the slants with Brain Heart Infusion Broth (BBL Microbiology Systems) and diluted to a density of 1 x 10⁸ CFU/ml. The trifluoroacetate salt of EM5587 was dissolved in the appropriate diluent at a concentration of 1,000 µg/ml. Two fold dilutions were made in Yeast Beef Broth (Difco) resulting in a range from 1,000 µg/ml. A 1.5 ml sample of each dilution was placed into individual petri dishes to which 13.5 ml of DST agar (Oxoid USA, Inc. Red Branch Road, Columbia, Maryland) containing 5% lysed sheep blood and 0.5 µg/ml vitamin K was added. The final drug concentration in the agar ranged from 100 µg/ml to 0.05 µg/ml. Organism growth control plates containing agar only were prepared and inoculated before and after the test plates. The organisms were applied to the surface of each plate with the Denly Multipoint Inoculator (which delivers approximately 0.001 ml of each organism) resulting in a final inoculum level of 10⁵ CFU on the agar surface. Plates were incubated at 37°C for 18 hours in an anaerobic chamber (Forma Scientific, Marietta, Ohio) and the MIC values then determined. The MIC is the lowest concentration of antibiotic inhibiting growth of the organism. The results of the agar dilution assays are: Organism SC No. MIC (µg/ml) Clostridium difficile 11251 0.2 Clostridium perfringens 11256 0.4 Clostridium histolyticum 8572 0.8 Clostridium septicum 1780 0.1 Peptococcus variabilis 11264 0.2 Peptostreptococcus anaerobius 11263 0.8 Propionibacterium acnes 4020 0.1 Eubacterium lentum 11261 0.4 Bifidobacterium dentium 11260 0.4 Hemophilus vaginalis 8568 0.8 Hemophilus vaginalis 9640 0.8 Fusobacterium necrophorum 10338 25.0 Bacteroides fragilis 9844 50.0 Bacteroides fragilis 10277 25.0 Bacteroides thetaiotaomicron 9005 12.5 Bacteroides thetaiotaomicron 10278 25.0

Claims: Claims for the following Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE A pharmaceutically acceptable salt of EM5587; the trifluoroacetate salt of EM5587 having the approximate elemental analysis C,50.01, H,6.92, N,13.98, F,7.4, having an ultraviolet spectrum as in Figure 1, having an infrared spectrum as in Figure 2, having a mass spectrum as in Figure 3, having a 67.5 MHz ¹³C NMR spectrum as in Figure 4, and having a 400 MHz ¹H NMR spectrum as in Figure 5. A process for preparing a salt of EM5587 as defined in claim 1 which comprises cultivating Lysobacter sp. SC 14,067 A.T.C.C. No. 53042 in a culture medium containing assimilable carbohydrate and nitrogen sources, and then recovering EM5587 from the medium as a salt. A process in accordance with claim 2 wherein the organism is cultivated at about 25°C. A biologically pure culture of the microorganism Lysobacter sp. SC 53042, said culture being capable of producing EM5587 as defined in claim 1 in a recoverable quantity upon fermentation in an aqueous nutrient medium containing assimilable sources of nitrogen and carbohydrates. Claims for the following Contracting State : AT A process for preparing a pharmaceutically acceptable salt of EM5587; the trifluoroacetate salt of EM5587 having the approximate elemental analysis C,50.01, H,6.92, N,13.98, F,7.4, having an ultraviolet spectrum as in Figure 1, having an infrared spectrum as in Figure 2, having a mass spectrum as in Figure 3, having a 67.5 MHz ¹³C NMR spectrum as in Figure 4, and having a 400 MHz ¹H NMR spectrum as in Figure 5, which comprises cultivating Lysobacter sp. SC 14,067 A.T.C.C. No. 53042 in a culture medium containing assimilable carbohydrate and nitrogen sources, and then recovering EM5587 from the medium as a salt. A process in accordance with claim 1 wherein the organism is cultivated at about 25°C. A biologically pure culture of the microorganism Lysobacter sp. SC 53042, said culture being capable of producing EM5587 as defined in claim 1 in a recoverable quantity upon fermentation in an aqueous nutrient medium containing assimilable sources of nitrogen and carbohydrates.

Inventors: KIRSCH, DONALD R., MCCULLOUGH, JOHN E., O'SULLIVAN, JOSEPH, TYMIAK, ADRIENNE A.
Applicants: E.R. SQUIBB & SONS, INC.
Application year: 1986
Main classification: C12P1
IPC codes: C07G11, A61P31, C12P1, A61K35, C12R1